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Abstract
Constituent chemicals in garlic extract are known to induce phase I and phase II enzymes in rodent livers. Here we have
utilized Car
+/+ and Car
2/2 mice to demonstrate that the nuclear xenobiotic receptor CAR regulated the induction of the
estrogen sulfotransferase Sult1e1 gene by diallyl sulfide (DAS) treatment in mouse liver. DAS treatment caused CAR
accumulation in the nucleus, resulting in a remarkable increase of SULT1E1 mRNA (3,200 fold) and protein in the livers of
Car
+/+ females but not of Car
2/2 female mice. DAS also induced other CAR-regulated genes such as Cyp2b10, Cyp3a11 and
Gadd45b. Compared with the rapid increase of these mRNA levels, which began as early as 6 hourrs after DAS treatment,
the levels of SULT1E1 mRNA began increasing after 24 hours. This slow response to DAS suggested that CAR required an
additional factor to activate the Sult1e1 gene or that this activation was indirect. Despite the remarkable induction of
SULT1E1, there was no decrease in the serum levels of endogenous E2 or increase of estrone sulfate while the clearance of
exogenously administrated E2 was accelerated in DAS treated mice.
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Introduction
Garlic has been consumed for food and medicinal purposes
worldwide for thousands of years. Garlic’s beneficial effects on
human health have been known for a long time. Currently, the
garlic plant itself as well as its numerous extracts are
commercially available as dietary supplements. Epidemiological
studies suggest garlic consumption has preventive effects for some
types of gastric cancer [1–3]. The pharmacological basis for these
preventive effects of garlic consumption have been suggested to
be due to the inductions of various hepatic drug-metabolizing
phase I and phase II enzymes [4–8]. Many of these enzymes are
also induced by various CAR activators such as phenobarbital,
phenytoin and TCPOBOP [9–13]. Whether CAR is essential for
garlic extracts to induce these enzymes, however, has not been
well established.
CAR, an orphan member of the nuclear steroid hormone
receptor superfamily, was first found to trans-activate the CYP2B
genes following phenobarbital and TCPOBOP treatment [14,15].
Subsequent investigations have characterized CAR as a xenobi-
otic-activated nuclear receptor, extended CAR activators to
include numerous xenobiotics and endobiotics, and increased
the large number of CAR-regulated genes [9,16–22]. As a result,
the role of CAR has also widened from drug metabolism to various
other hepatic functions such as energy homeostasis [23–26]. Upon
xenobiotic activation, CAR is also known to become a risk factor
that mediates the development of liver injuries such as steatosis,
and hepatocellular carcinoma [27–30]. If, in fact, garlic activates
CAR, this activation may have a wide range of both physiological
and pathophysiological consequences.
Estrogen sulfotransferase (EST) encoded by Sult1e1 and
SULT1E1 genes in mice and humans, respectively, is a phase II
drug metabolizing enzyme localized in the cytoplasm [31,32].
Biochemical and enzyme kinetic analysis have shown that ESTs in
mice and humans catalyze the conjugation of a sulfate group at the
3-hydroxyl position of estrogens at their physiological concentra-
tions [33–35]. Since sulfated estrogens do not bind the estrogen
receptor as effectively, EST is considered to be a major factor for
estrogen inactivation and metabolism [31,32]. In fact, gene
targeting disruption of Sult1e1 caused elevated estrogen levels
systemically and in the amniotic fluid in pregnant mice [36]. On
the other hand, sulfated estrogen circulating in the blood can be
converted to estrogen at the target tissues by steroid sulfatase.
Thus estrogen sulfotransferase works not only for elimination of
estrogen but also to produce precursors for active estrogen in a
form that is more soluble and easy to deliver to the peripheral
tissues [31,32].
Here we have found that DAS, a major component of garlic
extract, induced the estrogen sulfotransfease Sult1e1 gene in mouse
livers and we have investigated the role of CAR in this induction
using Car
2/2 mice. In addition, serum estrogen levels and estrogen
clearance were measured to determine whether SULT1E1
induction by DAS modulated the plasma levels of estrogens.
Results
Sult1e1 gene induction in mouse liver
Sutl1e1 gene expression was analyzed in wild type and Car null
female mice treated with DAS and DADS as described in the
methods section. DAS dramatically induced (250-fold) the gene
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21229expression at 24 hrs after DAS gastric administration (Fig. 1a). In
contrast, only a marginal induction (7.3 fold) of the same gene was
observed in Car null mice. Conversely, diallyl disulfide (DADS)
induces this gene 1.9 fold in wild type mice and 15.5 fold in Car
null mice, suggesting that this chemical does not activate CAR for
Sult1e1 gene induction. In agreement with mRNA expression,
SULT1E1 protein in liver cytosol was induced by DAS as shown
in the western blot in Fig. 1b, left panel, while in Car null mice
livers, DAS had negligible effects on the protein content. The
protein detected by the anti-SULT1E1 antibody co-migrated with
recombinant mouse SULT1E1 protein on the SDS-PAGE gel.
The estrogen sulfotransferase activity of the liver extracts used in
Fig. 1a is shown in Fig. 1b right panel. These results were well
consistent with the detected mRNA levels and protein levels in
Fig. 1a and Fig. 1b. Next, we analyzed changes in CAR protein
content in the nucleus of liver cells following DAS treatment, since
Figure 1. CAR dependent Sult1e1 gene induction. (A) Wild type and Car null mice were given DAS (80 mg/100 g body weight) or DADS (8 mg/
100 g body weight) by gastric gavage. 24 hrs after chemical administration, Sult1e1 and Car gene expression was analyzed by quantitative PCR as
described in the methods section. The relative mRNA amount of each gene was calculated so that wild type vehicle treated samples have one unit of
expression. (B) Left panel; Liver cytosol extracts from the same mice used in (A) were prepared and SULT1E1 protein content was analyzed by western
blotting. Recombinant mouse SULT1E1 protein was used as positive control and indicated with R, while V represents vehicle treatment. Anti Hsp70
western blotting is shown as a loading control. Right panel; Estrogen sulfotransferase activities were measured for liver extracts from the same mice
used in (A). n.d. stands for no activity detected. (C) Liver nuclear extracts from the same mice used in (A) were prepared and CAR protein content was
analyzed by western blotting. Anti Laminb western blotting is shown as a loading control.
doi:10.1371/journal.pone.0021229.g001
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upon its activation. Thus, we analyzed CAR protein levels in
mouse liver nuclear extracts before and after DAS administration.
We observed that levels of CAR protein in the nucleus were
increased by DAS and DADS administration in wild type animals,
while no CAR protein was detected with the same antibody in Car
null mice nuclear extracts. The effect of DAS was so dramatic that
the CAR protein content in the nucleus was much higher than that
of PB treated mice. The reason why DADS activates CAR for
nuclear translocation but not for Sult1e1 gene activation may be
an interesting topic for research in the future.
Gene inductions in DAS treated wild type and Car null
mice
In DAS treated mouse liver, other xenobiotic metabolizing
enzymes were also induced as shown in Fig. 2. The most
extensively analyzed CAR dependent gene in mouse liver,
Cyp2b10, was markedly induced almost to the same extent (216
fold) as Sult1e1 while no induction of this gene was observed in Car
null mice. In the case of Cyp3a11and Gadd45b, significant induction
was observed in wild type mice while less induction was found in
Car null mice. For Cyp1a1, no gene induction was observed in Car
null mice while significant induction was observed in wild type
mice, suggesting that CAR plays a critical role in the induction of
Cyp1a1 by DAS. These observations suggest that there may be
regulatory elements in the mouse Cyp1a1 gene that can be
activated by CAR, as in the case of the human CYP1A1 gene [37].
Time course Sult1e1 gene activation by DAS
Next, we analyzed the time course of the increase of gene
expression after DAS treatment. Sult1e1 and Cyp2b10 gene
expression was analyzed at 6, 24, 48, 72, and 96 hrs after DAS
gavage (Fig. 3a). Cyp2b10 was very quickly induced compared to
Sult1e1. At 6 hrs, Cyp2b10 induction was already at the maximum
while Sult1e1 induction was very low at this point. Sult1e1
expression levels increased up to 48 hrs after DAS treatment to
over 3000 fold and then decreased to an almost basal level at
72 hrs. In contrast, Cyp2b10 expression was gradually decreased
from its 6 hr maximum (110 fold) to 60 fold at 48 hrs, and
returned to basal levels at 72 hrs. In the meantime, we observed
strong CAR accumulation in the nucleus at 6, 24, and 48 hrs while
no CAR protein existed in the nucleus at 72 or 96 hrs (Fig. 3b).
This dramatic difference in the time course for induction of these
two genes suggests that partially independent mechanisms are
playing roles for the induction of each gene. The time courses for
induction of the Cyp3a11 and Gadd45b genes were intermediate to
those of Sult1e1 and Cyp2b10, with maximum expression at 24 hrs
and decreasing gradually to the basal level at 72 hr or 96 hrs.
Figure 2. Gene activation by DAS. The expression of Cyp2b10, Cyp3a11, Gadd45b and Cyp1a1 genes was analyzed in DAS treated and vehicle
treated mice livers. The same RNA samples treated with vehicle or DAS from wild type and Car null mice liver used in FIG. 1A were analyzed to
determine the expression of these genes.
doi:10.1371/journal.pone.0021229.g002
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We analyzed serum estrogen levels in DAS-treated mice.
Surprisingly there was slight increase in estrogen levels in the
serum of 4 week old mice after DAS treatment (Fig. 4a). Estrone
sulfate levels in serum did not change with the same treatment
(Fig. 4b). Thus we measured the clearance of exogenously
administrated estrogen in ovariectomized mice with or without
DAS pretreatment for 42 hrs to allow for maximal induction of the
Sult1e1 gene. Then, the mice were administrated with estrogen
(0.5 mg/kg) and estrogen levels in serum were determined at 3, 8,
and 24 hrs after the administration (Fig. 4c). E2 was shown to be
very rapidly cleared from the serum and at 24 hrs following
administration, E2 levels in DAS treated and control mice were
the same as the basal levels found in non E2 administered mice. At
3 hrs after E2 administration, the E2 levels in DAS treated mice
were significantly lower than those of non treated mice, while at
8 hrs no difference was observed.
Discussion
Naturally-occurring organosulfur compounds including DAS
found in garlic and onions can induce diverse phase I and phase II
enzymes in mice and rats [4,5,8]. Many of these enzyme
inductions seem to be mediated by CAR activation [6,7,38].
These gene inductions affect endogenous and exogenous chemical
metabolism and the gene expression and metabolism change
brought by garlic consumption should explain garlic’s beneficial
effect on the body. Epidemiological studies established garlic’s
preventive effects for colorectal and stomach cancer [1–3]. Cancer
incidents in other sites (head and neck, lung, breast, and prostate)
are also suggested to be reduced with garlic consumption.
Furthermore, Sult1e1 polymorphisms are shown to be a risk factor
for breast and endometrial cancers [39–41]. Thus, where CAR and
SULT1E1 genes are co-expressing, garlic may affect cancer
formation and development by affecting SULT1E1 gene expres-
sion. However, there are no overall clear connections between the
animal model studies and human epidemiological studies estab-
lished so far. One group has shown that organosulfur compounds
can reduce aflatoxin B1 genotoxicity in rats by inducing phase I
and phase II enzymes that increase the metabolism of aflatoxin B1
[4]. Since garlic extract can affect the expression of diverse genes
thus resulting in many changes in biological processes, much
additional work is necessary using human tissue derived model
systems in order to establish the relevance of animal model
findings on human health.
In this report we observed a very strong induction of the Sult1e1
gene in the mouse liver by gastrically injected DAS. CAR is a
dominant factor in the induction of this gene, since only a
marginal induction of this gene was observed in Car null mice.
Recently, mouse Sult1e1 was shown to be induced by many
chemicals that activate CAR [11]. Among these chemicals,
TCPOBOP, a specific mouse CAR agonist, showed more potent
Figure 3. Gene induction time course. (A) Wild type and Car null
mice were given DAS (80 mg/100 g body weight) by gastric gavage. B.
Following 6, 24, 48, 72, and 96 hrs after chemical administration, the
expression of Sult1e1, Cyp2b10, Cyp3a11, and Gadd45b genes was
analyzed by quantitative PCR as described in the methods section. The
relative mRNA amount of each gene was calculated so that wild type
vehicle treated samples have one unit of expression. (B) Liver nuclear
extracts from DAS treated mice at indicated time after the chemical
administration were prepared and CAR protein content was analyzed
by western blotting. Anti TATA binding protein (TBP) western blotting is
shown as a loading control.
doi:10.1371/journal.pone.0021229.g003
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mice in this report and we observed slightly less Sult1e1 induction
in male mice by DAS treatment (data not shown).
The Sult1e1 gene induction time course was found to be unique
as shown in Fig. 3. Other canonical genes induced by CAR
activation had their highest expressions between 6–24 hrs. In
contrast, Sult1e1 gene induction was optimum at 48 hrs after
chemical administration. This observation suggests secondary
factors which are activated by CAR are involved in Sult1e1 gene
induction. Recently, the paracrine regulatory mechanism of the
SULT1E1 gene was characterized in HepG2 cells co-cultured with
MMNK-1 cholangiocytes [42,43]. When HepG2 cells were co-
cultured with CFTR siRNA treated MMNK-1 cells in a Transwell
system, an unidentified factor secreted from MMNK-1 cells that is
permeable through the Transwell membrane activated SULT1E1
gene expression in HepG2 cells. Whether such a paracrine
mechanism is involved in Sult1e1 induction by DAS, thus causing a
slow gene induction in contrast to other CAR responsive genes,
remains unanswered at this point. Another recent report suggests
that RORa suppresses Sult1e1 expression in mice [44]. The broad
spectrum of RORa and RORc in the regulation of phase I and
phase II genes implies that these receptors have crosstalk with
CAR. Whether such a crosstalk plays a role or not in Sult1e1 gene
induction by DAS will be an interesting research target.
A striking finding of this report is that the strong Sult1e1 gene
induction did not affect the endogenous E2 level while improved
E2 elimination was observed when the hormone was exogenously
administered to ovariectomized mice. A recent report demon-
strated that E2 decreased in mice when the Sult1e1 gene was
induced in mouse livers by glucocorticoid [45]. They suggested
that one of the mechanisms by which glucocorticoid attenuates
E2’s biological effect is augmenting Sult1e1 expression in the liver
so that conversion of serum E2 to its sulfated form for eventual
secretion from the body is accelerated. In contrast, although DAS
treated mice have robust Sult1e1 induction (around 3200 fold),
endogenous E2 was not affected although exogenous E2 clearance
was faster as shown in Fig. 4. These results suggest that Sult1e1 in
the liver may not be the dominant regulator for the E2 levels in the
mice of our experimental systems. One additional point is that the
endogenous E2 levels were analyzed in 4 week old female mice
while 8 week old ovariectomized mice were used for E2
elimination experiment. Although the Sult1e1 gene in liver was
induced in both cases (data not shown), we don’t know if this age
difference can affect the whole body response to DAS. Moreover,
DAS may have effect on estradiol synthesis pathways, estradiol
turnover or expression/activity of SULT1E1 in the tissues other
than liver. Further detailed pharmacokinetical, pharmacogeneti-
cal, and biochemical studies are necessary to determine why this
strong induction of Sult1e1 does not alter serum E2 levels.
Materials and Methods
Animals
Car null mice with C3H/HeNCrlBR (C3H) genetic background
were established as previously described [28]. Mice were kept in
12:12h dark/light cycle and fed with a standard solid diet ad
libitum. C3H wild type and Car null female mice received DAS
(80 mg/100 g body weight) and DADS (8 mg/100 g) via gavage
using corn oil as the vehicle. Phenobarbital (1 mg/100 g) dissolved
Figure 4. The effect of DAS treatment on serum estrogen. (A) E2
levels in sera from 4 week old mice treated with vehicle or DAS for
48 hrs are shown. * p,0.05 for vehicle-injected group versus DAS-
injected group. (B) Estrone sulfate levels in sera from 8 week old female
mice treated with vehicle or DAS for 48 hrs are shown. (C) The clearance
of exogenously administered E2 from mice sera was analyzed using
DAS treated and vehicle treated ovariectomized mice. Ovariectomized
mice were given DAS via gavage and E2 (0.5 mg/kg) was injected
subcutaneously 42 hrs after the DAS administration. The E2 content in
serum was determined by radioimmunoassay and plotted against time
after E2 treatment. **, p,0.01 for vehicle-injected group versus DAS-
injected group at 3 hrs after E2 treatement.
doi:10.1371/journal.pone.0021229.g004
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at specified hours after the administration of xenobiotics for liver
RNA or serum preparation. All animal procedures were approved
by the Animal Ethics Committee at NIEHS, NIH (Permit
Number: ASP 00-19).
Chemicals
DAS (allyl sulfide, 97%) and DADS (allyl disulfide, 80%) were
purchased from Sigma.
Real Time RT PCR
Total mouse liver (three C3H female mice for each data point)
RNA was isolated with Trizol reagent (Invitrogen) and reverse
transcription was performed using High Capacity cDNA Archive
kits for the RNA. Quantitative real-time PCR was carried out with
the 7900HT Fast Real Time PCR System (Applied Biosystems).
For Nr1i3, FAM-CCATGACAGCTATGCTAA-MGB probe was
used with 59-CCTGCTGCCTAAGGGAAACAG-3- and 59-
TCTTCACTGGCCATGGTTTCTA-39 primers. For Sult1e1,
Cyp2b10, Cyp3a11, Gadd45b and Cyp1a1, pre-synthesized probes
from ABI, Mm00499178_m1, Mm00456591_m1, Mm00731567,
Mm00435123_m1, and Mm00487218_m1 were used, respective-
ly. For normalization of gene expressions among individual mice,
Gapdh gene expressions determined with TaqMan rodent glycer-
aldehyde-3-phosphate dehydrogenase control reagent (Applied
Biosystems) were utilized.
Western blotting
Mouse liver cytosol and nuclear extracts from C3H female mice
were prepared as described previously [46]. Individual mouse liver
extracts and pooled nuclear extracts from 3 mice were used for
western blotting. The protein concentration of extracts was
determined using the Bio-Rad Protein Assay reagent. Thirty and
100 mg protein samples for nuclear extracts and cytosol extracts
respectively were separated on a SDS-PAGE gel and transferred to
PVDF membranes. Anti SULT1E1 and recombinant mouse
SULT1E1 were described in the previous report [47]. Anti CAR
monoclonal antibody developed by Perseus Proteomics (Tokyo,
Japan) was purchased from R&D Systems (Minneapolis, MN). Anti
HSP70 and anti lamin b were from BD Biosciences (San Jose, CA)
and Santa Cruz Biotechnology (Santa Cruz, CA), respectively.
Estrogen sulfotransferase activity
Estrogen sulfotransferase activities of liver extracts were
determined as described previously [47]. Briefly, liver extracts
were incubated with 2 mM
3H labeled estradiol and 100 mM3 9-
Phosphoadenosine-59-phosphosulfate in 200 mM Tris-acetate
(pH 8.0) buffer containing 10 mM magnesium acetate. The
samples were incubated at 37uC for 30 min and extracted with
dichloromethane. The
3H label in the aqueous phase was counted
to measure sulfated estradiol.
Serum estrogen
Ovariectomized or non-operated female C3H mice (7weeks old)
and female C3H mice (4 weeks old) were obtained from Jackson
Laboratory (Bar Harbor, ME). For E2 clearance analysis,
ovariectomized mice were treated with DAS or corn oil (vehicle)
via gavage. Forty two hours after DAS treatment, beta E2
(0.5 mg/kg) was administrated subcutaneously. At 3, 8, and 24 hrs
after E2 administration, mice were sacrificed for liver RNA
preparation while blood samples were collected from the inferior
vena cava. For endogenous E2 levels in 4 week old mice, mice
were treated with DAS or vehicle. Serum and RNA were prepared
at 48 hrs after the treatment. For estrone sulfate determination, 7
weeks old female C3H mice were utilized for DAS or vehicle
treatment (48 hrs). Serum was isolated with BD Microtainer serum
separator tubes (Becton, Dickinson and Co., Franklin Lakes, NJ).
Serum E2 and estrone sulfate concentrations were determined
with DSL-4800 Ultra-Sensitive Estradiol RIA kit and DSL-5400
Estrone Sulfate RIA kit (Beckman Coulter, Brea, CA).
Statistical analysis
Statistical analysis was performed by Student’s t test to compare
the estradiol elimination difference between vehicle and DAS
treated C3H female mice.
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